Table 1 Canadian cancer screening guidelines from the Canadian Task Force on Preventive Health Care (CTFPHC) and the Canadian Cancer Society (CCS)
From: Adherence to cancer screening guidelines across Canadian provinces: an observational study
| Â | Breast Cancer | Colorectal Cancer | Prostate Cancer |
|---|---|---|---|
| Â | CTFPHC (2001) [44] | CTFPHC (2001) [45] | CTFPHC (2000) [46] |
Test | Mammography | FOBT (good evidence); sigmoidoscopy (fair evidence); insufficient evidence to include or exclude colonoscopy | PSA |
Periodicity | Every 1-2 years | Every 1 to 2 years; periodicity unspecified | Not be used due to low positive predictive value and risk of adverse affects associated with treatment |
Population | Asymptomatic women ages 50-69 | Asymptomatic individuals age 50+ | NA |
| Â | CCS (2005) [47] | CCS(2005) [48] | CCS (2005) [49] |
Test | Mammography | FOBT | PSA |
Periodicity | Every 2 years | At least every 2 years | Discuss with physician the benefits and risks |
Population | Asymptomatic women ages 50-69 | Asymptomatic individuals age 50+ | Men age 50+ |